Ana Hickey
Overview
Explore the profile of Ana Hickey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
le Roux C, Hankosky E, Wang D, Malik R, Yu M, Hickey A, et al.
Diabetes Obes Metab
. 2023 Jun;
25(9):2626-2633.
PMID: 37344384
Aim: To compare the efficacy of tirzepatide 10 and 15 mg with semaglutide 2.4 mg using an indirect treatment comparison. Materials And Methods: Using SURMOUNT-1 and STEP 1 trial data,...
2.
Franek E, Pais P, Basile J, Nicolay C, Raha S, Hickey A, et al.
Cardiovasc Diabetol
. 2023 Mar;
22(1):52.
PMID: 36899386
Background: In clinical practice, anthropometric measures other than BMI are rarely assessed yet may be more predictive of cardiovascular (CV) risk. We analyzed the placebo group of the REWIND CV...
3.
Kiyosue A, Dunn J, Cui X, Hickey A, Hirase T, Imaoka T, et al.
Diabetes Obes Metab
. 2022 Dec;
25(4):1056-1067.
PMID: 36545807
Aim: To assess the safety and efficacy of tirzepatide in people of East Asian descent based on age and body mass index (BMI). Materials And Methods: Data of participants enrolled...
4.
Franek E, Gerstein H, Riddle M, Nicolay C, Hickey A, Botros F, et al.
Diabetes Obes Metab
. 2022 May;
24(9):1753-1761.
PMID: 35546279
Aim: To assess cardiovascular, glycaemic, weight and safety outcomes of long-term treatment with dulaglutide 1.5 mg compared with placebo in patients with a baseline HbA1c of less than 7% versus...
5.
Udayan S, Stamou P, Crispie F, Hickey A, Floyd A, Hsieh C, et al.
Gut Microbes
. 2022 Jan;
14(1):2007743.
PMID: 35023810
In healthy hosts the gut microbiota is restricted to gut tissues by several barriers some of which require MyD88-dependent innate immune sensor pathways. Nevertheless, some gut taxa have been reported...
6.
Aguilera M, Rossini V, Hickey A, Simnica D, Grady F, Felice V, et al.
Int J Mol Sci
. 2021 Aug;
22(15).
PMID: 34361102
Interactions between the intestinal microbiota, immune system and nervous system are essential for homeostasis in the gut. Inflammasomes contribute to innate immunity and brain-gut interactions, but their role in microbiota-neuro-immune...
7.
Hickey A, Stamou P, Udayan S, Ramon-Vazquez A, Esteban-Torres M, Bottacini F, et al.
Front Microbiol
. 2021 Jul;
12:653587.
PMID: 34220742
Exopolysaccharide (EPS) is a bacterial extracellular carbohydrate moiety which has been associated with immunomodulatory activity and host protective effects of several gut commensal bacteria. are early colonizers of the human...
8.
Katarzyna Oficjalska , Raverdeau M, Aviello G, Wade S, Hickey A, Sheehan K, et al.
J Immunol
. 2014 Dec;
194(3):1252-60.
PMID: 25548224
Activation of the noncanonical inflammasome, mediated by caspase-11, serves as an additional pathway for the production of the proinflammatory cytokines IL-1β and IL-18. Noncanonical inflammasome activity occurs during host defense...